Food/Recall·openFDA/food

Zarlengo Italian Ice — Class II: Zarlengo's Double Dark Chocolate Gelato packaged in 1 Gallon bucket/pail - white round foo

MediumPublished Apr 15, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Zarlengo Italian Ice has initiated a Class II recall for its Double Dark Chocolate Gelato in one-gallon pails because Soy Lecithin is listed in the ingredients, but Soy is not declared in the allergen 'Contains' statement.

Who it affects

This recall affects Zarlengo Italian Ice, food labeling professionals, and QA teams involved in the production and distribution of frozen dessert products.

Why it matters

Failure to reconcile the ingredient list with the allergen declaration represents a significant regulatory non-compliance. While categorized as Class II, this suggests a breakdown in the labeling review process where sub-components of ingredients (like soy lecithin) were not adequately mapped to mandated allergen disclosures, potentially posing a risk to sensitive consumers.

Practical takeaway

QA and labeling departments should conduct an immediate audit of product labels to ensure alignment between 'Ingredients' and 'Contains' statements. Regulatory teams should confirm that all soy-derived components, such as soy lecithin, are explicitly declared in allergen statements to maintain compliance with federal labeling requirements.

FDA source material

Class II. Reason: Soy Lecithin listed in ingredients statement, but Soy is not mentioned in the contains statement.. Product: Zarlengo's Double Dark Chocolate Gelato packaged in 1 Gallon bucket/pail - white round food and freezer grade High-Density Polyethylene bucket/pail with tamper resistant lid.. Firm: Zarlengo Italian Ice (Chicago Heights IL United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.